| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CEO | Interim CEO
1 company
Woods Lori A is a Director at Perspective Therapeutics, Inc.. Recent SEC Form 4 filings include 15 buys and 0 sells.
Estimated insider holdings value: $687K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | CATX Perspective Therapeutics, Inc. | Director | Buy | 23,475 | $2.13 | $49,999.40 | +14.7% | +61.5% | +95.8% | |
| Jun 14, 2024 | CATX Perspective Therapeutics, Inc. | Director | Buy | 4,587 | $10.90 | $49,990.00 | +1.5% | +48.0% | -70.4% | |
| Jun 3, 2024 | CATX Perspective Therapeutics, Inc. | Director | Buy | 34,246 | $1.46 | $49,992.31 | +2.3% | +3.5% | -77.4% | |
| Dec 15, 2023 | CATX Perspective Therapeutics, Inc. | Director | Buy | 185,200 | $0.27 | $49,988.70 | +6.9% | +299.7% | +30.0% | |
| Nov 15, 2022 | CATX Perspective Therapeutics, Inc. | CEO | Buy | 100,000 | $0.34 | $33,540.00 | +9.6% | +12.1% | -23.7% | |
| Jun 7, 2022 | CATX Perspective Therapeutics, Inc. | CEO | Buy | 75,000 | $0.30 | $22,230.00 | +7.7% | +23.3% | +94.3% | |
| Nov 30, 2020 | CATX Perspective Therapeutics, Inc. | CEO | Buy | 68,000 | $0.38 | $25,534.00 | +12.5% | - | - | |
| Oct 22, 2020 | CATX Perspective Therapeutics, Inc. | CEO | Buy | 48,076 | $0.52 | $24,999.52 | New | - | - | |
| Nov 15, 2019 | CATX Perspective Therapeutics, Inc. | CEO | Buy | 150,000 | $0.40 | $59,295.00 | +39.0% | - | - | |
| Nov 15, 2018 | CATX Perspective Therapeutics, Inc. | Interim CEO | Buy | 130,000 | $0.40 | $51,730.98 | +51.1% | - | - |